Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 1
2021 7
2022 8
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Sinnberg T, Lichtensteiger C, Ali OH, Pop OT, Jochum AK, Risch L, Brugger SD, Velic A, Bomze D, Kohler P, Vernazza P, Albrich WC, Kahlert CR, Abdou MT, Wyss N, Hofmeister K, Niessner H, Zinner C, Gilardi M, Tzankov A, Röcken M, Dulovic A, Shambat SM, Ruetalo N, Buehler PK, Scheier TC, Jochum W, Kern L, Henz S, Schneider T, Kuster GM, Lampart M, Siegemund M, Bingisser R, Schindler M, Schneiderhan-Marra N, Kalbacher H, McCoy KD, Spengler W, Brutsche MH, Maček B, Twerenbold R, Penninger JM, Matter MS, Flatz L. Sinnberg T, et al. Among authors: scheier tc. Am J Respir Crit Care Med. 2023 Jan 1;207(1):38-49. doi: 10.1164/rccm.202201-0011OC. Am J Respir Crit Care Med. 2023. PMID: 35926164 Free PMC article.
Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020.
Gebhard CE, Sütsch C, Gebert P, Gysi B, Bengs S, Todorov A, Deforth M, Buehler PK, Meisel A, Schuepbach RA, Zinkernagel AS, Brugger SD, Acevedo C, Patriki D, Wiggli B, Beer JH, Friedl A, Twerenbold R, Kuster GM, Pargger H, Tschudin-Sutter S, Schefold JC, Spinetti T, Henze C, Pasqualini M, Sager DF, Mayrhofer L, Grieder M, Tontsch J, Franzeck FC, Wendel Garcia PD, Hofmaenner DA, Scheier T, Bartussek J, Haider A, Grämer M, Mikail N, Rossi A, Zellweger N, Opić P, Portmann A, von Känel R, Pazhenkottil AP, Messerli M, Buechel RR, Kaufmann PA, Treyer V, Siegemund M, Held U, Regitz-Zagrosek V, Gebhard C. Gebhard CE, et al. Among authors: scheier t. Euro Surveill. 2024 Jan;29(2):2300200. doi: 10.2807/1560-7917.ES.2024.29.2.2300200. Euro Surveill. 2024. PMID: 38214079 Free PMC article.
Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial.
West E, Zeeb M, Grube C, Kuster H, Wanner K, Scheier T, Neumann K, Jörimann L, Hampel B, Metzner KJ, Kouyos RD, Braun DL, Günthard HF. West E, et al. Among authors: scheier t. Clin Infect Dis. 2023 Oct 5;77(7):1012-1020. doi: 10.1093/cid/ciad366. Clin Infect Dis. 2023. PMID: 37338148 Free PMC article. Clinical Trial.
Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
Wolfensberger A, Kufner V, Zaheri M, Zeeb M, Nortes I, Schreiber PW, Vazquez M, Schärer V, Scheier T, Schmutz S, Probst E, Saleschus D, Huber M, Rampini SK, Zingg W. Wolfensberger A, et al. Among authors: scheier t. Emerg Infect Dis. 2022 Oct;28(10):2087-2090. doi: 10.3201/eid2810.220321. Epub 2022 Sep 1. Emerg Infect Dis. 2022. PMID: 36048771 Free PMC article.
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants.
Emmenegger M, Fiedler S, Brugger SD, Devenish SRA, Morgunov AS, Ilsley A, Ricci F, Malik AY, Scheier T, Batkitar L, Madrigal L, Rossi M, Meisl G, Lynn AK, Saleh L, von Eckardstein A, Knowles TPJ, Aguzzi A. Emmenegger M, et al. Among authors: scheier t. iScience. 2022 Aug 19;25(8):104766. doi: 10.1016/j.isci.2022.104766. Epub 2022 Jul 16. iScience. 2022. PMID: 35875683 Free PMC article.
Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.
Mairpady Shambat S, Gómez-Mejia A, Schweizer TA, Huemer M, Chang CC, Acevedo C, Bergada-Pijuan J, Vulin C, Hofmaenner DA, Scheier TC, Hertegonne S, Parietti E, Miroshnikova N, Wendel Garcia PD, Hilty MP, Buehler PK, Schuepbach RA, Brugger SD, Zinkernagel AS. Mairpady Shambat S, et al. Among authors: scheier tc. PLoS Pathog. 2022 Jan 10;18(1):e1010176. doi: 10.1371/journal.ppat.1010176. eCollection 2022 Jan. PLoS Pathog. 2022. PMID: 35007290 Free PMC article.
28 results